Codiak lands on Wall Street in second shot at IPO, raises $83M
Codiak Biosciences finally hit Wall Street on Tuesday in its second attempt to go public, but didn’t quite reach its $100 million goal.
The Cambridge …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
